Human evidence that the apolipoprotein A-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins

Circulation

Volumn 104, Issue 11, 2001, Pages 1223-1228

  Van't Hooft, Ferdinand M ^a   Ruotolo, Giacomo ^a   Boquist, Susanna ^a   De Faire, Ulf ^b   Eggertsen, Gösta ^a   Hamsten, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Apolipoproteins; Genetics; Lipoproteins; Metabolism; Obesity

Indexed keywords

APOLIPOPROTEIN A2; CYTOSINE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; NUCLEAR PROTEIN; STRUCTURAL PROTEIN; THYMINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; DNA POLYMORPHISM; ELECTROPHORETIC MOBILITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DNA BINDING; VISCERA;

EID: 0035845628     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3601.095709     Document Type: Article

References (29)

1. Apolipoprotein A-II. A protein in search of a function
2. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: The ECTIM study
3. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles
4. Cholesterol efflux, cholesterol esterification and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma
5. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice
6. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase: Studies in apoA-II and hepatic lipase double knockout mice
7. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity
8. ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion
9. Functional cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
10. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake
11. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice
12. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
13. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
14. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice
15. Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis
16. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance
17. Studies with apolipoprotein A-II transgenic mice indicate a role of HDLs in adiposity and insulin resistance
18. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility
19. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men
20. Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4
21. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons
22. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-I (PAI-I) gene respond differently to interleukin-I in HepG2 cells
23. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene
24. Promoter elements and factors required for hepatic transcription of the human apoA-II gene
25. Factors participating in the liver-specific expression of the human apolipoprotein A-II gene and their significance for transcription
26. Purification and characterization of nuclear factors binding to the negative regulatory element D of human apolipoprotein A-II promoter: A negative regulatory effect is reversed by GABP, an Ets-related protein
27. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans
28. DNA polymorphisms in linkage disequilibrium at the 3′ end of the APO AII gene: Relationships with lipids, apolipoproteins and coronary heart disease